Publication: 786

Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial
      QxMD      Google Scholar   
Citation:
Clin Breast Cancer vol 12 (2) 81-86
Year:
2012
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
1
Parents:
787  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180821, 25224  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
NCCTG-N0337
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
capecitabine, combination chemotherapy, metastatic breast cancer, trastuzumab, vinorelbine